in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Cambrex Opens API Facility in Sweden
11:42 PM MDT | March 12, 2009 | Deepti Ramesh
Cambrex says it has opened a previously announced $20-million active pharmaceutical ingredients (API) manufacturing facility at Karlskoga, Sweden. The new cGMP facility, which took two year to build, gives Cambrex Karlskoga a flexible production plant, which will increase large-scale production capacity for new APIs. Cambrex Karlskoga produces APIs and during the last ten years, the company has also supported innovative pharmaceutical companies with their drug development...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee